scholarly journals An assessment of the impact of the NHS Health Technology Assessment Programme

2007 ◽  
Vol 11 (53) ◽  
Author(s):  
S Hanney ◽  
M Buxton ◽  
C Green ◽  
D Coulson ◽  
J Raftery
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Assessment Programme ◽  
Health Technology Assessment Programme ◽  
The Impact

Routine use of progesterone does not prevent miscarriage

BMJ ◽  
2019 ◽  
pp. l5721
Author(s):  
Rob Cook ◽  
Vaughan Thomas ◽  
Rachel Taft
Keyword(s):  
Health Technology Assessment ◽  
Early Pregnancy ◽  
Technology Assessment ◽  
Randomised Trial ◽  
Health Technology ◽  
Assessment Programme ◽  
Link Type ◽  
Health Technology Assessment Programme

The studyCoomarasamy A, Devall AJ, Cheed V, et al. A randomised trial of progesterone in women with bleeding in early pregnancy N Engl J Med 2019;380:1815-24.This project was funded by the NIHR Health Technology Assessment Programme (project number 12/167/26).To read the full NIHR Signal, go to https://discover.dc.nihr.ac.uk/content/signal-000792/miscarriage-not-prevented-by-routine-use-of-progesterone

PRIORITIZING INVESTMENTS IN HEALTH TECHNOLOGY ASSESSMENT

2000 ◽  
Vol 16 (1) ◽  
pp. 73-91 ◽  
Author(s):  
Linda Davies ◽  
Michael Drummond ◽  
Panos Papanikolaou
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Costs And Benefits ◽  
Value For Money ◽  
Absolute Value ◽  
Prioritization Process ◽  
Health Care Interventions ◽  
Health Technology Assessment Programme ◽  
The Impact

Objective: The objective was to develop an economic prioritization model to assist those involved in the selection and prioritization of health technology assessment topics and commissioning of HTA projects.Methods: The model used decision analytic techniques to estimate the expected costs and benefits of the health care interventions that were the focus of the HTA question(s) considered by the NHS Health Technology Assessment Programme in England. Initial estimation of the value for money of HTA was conducted for several topics considered in 1997 and 1998.Results: The results indicate that, using information routinely available in the literature and from the vignettes, it was not possible to estimate the absolute value of HTA with any certainty for this stage of the prioritization process. Overall, the results were uncertain for 65% of the HTA questions or topics analyzed. The relative costs of the interventions or technologies compared to existing costs of care and likely levels of utilization were critical factors in most of the analyses. The probability that the technology was effective with the HTA and the impact of the HTA on utilization rates were also key determinants of expected costs and benefits.Conclusions: The main conclusion was that it is feasible to conduct ex ante assessments of the value for money of HTA for specific topics. However, substantial work is required to ensure that the methods used are valid, reliable, consistent, and an efficient use of valuable research time.

Sign in / Sign up

Export Citation Format

Share Document